Skip to main content
Log in

Fasting plasma glucose level to guide the need for an OGTT to screen for gestational diabetes mellitus

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 13 March 2023

Abstract

Aims

To determine the fasting plasma glucose (FPG) level at which an oral glucose tolerance test (OGTT) could be avoided to screen for gestational diabetes (GDM) and to evaluate the characteristics of women across this FPG threshold.

Methods

A multi-centric prospective cohort study with 1843 women receiving universal screening for GDM with a 75 g OGTT.

Results

In the total population, GDM prevalence was 12.5% (231). A FPG < 78 mg/dL was the cut-off with best trade-off to limit the number of missed GDM cases [44 (19.0%)] with a negative predictive value of 97.3% (95% CI 96.5–98.0) for GDM, while avoiding 52.2% OGTTs. Compared to GDM with FPG ≥ 78 mg/dL [187 (81.0%)], GDM women with FPG < 78 mg/dL had a significantly lower BMI (27.1 ± 4.5 vs. 29.6 ± 5.2 kg/m2, p = 0.003), less insulin resistance [Matsuda: 0.4 (0.4–0.7) vs. 0.3 (0.2–0.5), p < 0.001] and better β-cell function [ISSI-2: 0.13 (0.08–0.25) vs. 0.09 (0.04–0.15), p = 0.004]. Compared to NGT women (1612) with FPG ≥ 78 mg/dL [846 (52.5%)], NGT with FPG < 78 mg/dL [766 (47.5%)] had a significantly lower BMI (26.0 ± 3.9 vs. 27.8 ± 4.7 kg/m2, p < 0.001), less insulin resistance [Matsuda: 0.7 (0.5–0.9) vs. 0.5 (0.4–0.7), p < 0.001], better β-cell function [ISSI-2: 0.17 (0.10–0.30) vs. 0.12 (0.07–0.21), p < 0.001], and less often large-for-gestational age infants [9.2 (70) vs. 16.2% (136), p < 0.001].

Conclusions

FPG < 78 mg/dL can be used to limit the number of OGTTs when screening for GDM. Women with FPG < 78 mg/dL had a better metabolic profile and in NGT women also less fetal overgrowth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

All data generated or analyzed during this study are included in this published article.

References

  1. American Diabetes Association (2021) Addendum. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes. Diabetes Care 44(Suppl. 1):S15–S33. https://doi.org/10.2337/dc21-ad09

    Article  Google Scholar 

  2. Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352(24):2477–2486. https://doi.org/10.1056/NEJMoa042973

    Article  CAS  PubMed  Google Scholar 

  3. Landon MB, Spong CY, Thom E et al (2009) A multicenter randomized trial of treatment for mild gestational diabetes. N Engl J Med 361(14):1339–48. https://doi.org/10.1056/NEJMoa0902430

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Benhalima K, Mathieu C, Damm P et al (2015) A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG). Diabetologia 58(7):1422–9. https://doi.org/10.1007/s00125-015-3615-7

    Article  PubMed  Google Scholar 

  5. O’Sullivan JB, Mahan CM (1964) Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13:278–285

    CAS  PubMed  Google Scholar 

  6. Carpenter MW, Coustan DR (1982) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144(7):768–773. https://doi.org/10.1016/0002-9378(82)90349-0

    Article  CAS  PubMed  Google Scholar 

  7. Metzger BE, Buchanan TA, Coustan DR et al (2007) Summary and recommendations of the fifth international workshop-conference on gestational diabetes mellitus. Diabetes Care 30(Suppl 2):S251-60. https://doi.org/10.2337/dc07-s225

    Article  CAS  PubMed  Google Scholar 

  8. Metzger BE et al (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3):676–682. https://doi.org/10.2337/dc09-1848

    Article  CAS  PubMed  Google Scholar 

  9. Metzger BE, Contreras M, Sacks DA et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358(19):1991–2002. https://doi.org/10.1056/NEJMoa0707943

    Article  PubMed  Google Scholar 

  10. Agarwal MM, Punnose J, Dhatt GS (2004) Gestational diabetes: problems associated with the oral glucose tolerance test. Diabetes Res Clin Pract 63(1):73–74. https://doi.org/10.1016/j.diabres.2003.08.005

    Article  CAS  PubMed  Google Scholar 

  11. Benhalima K, Van Crombrugge P, Moyson C et al (2018) A Modified two-step screening strategy for gestational diabetes mellitus based on the 2013 WHO criteria by combining the glucose challenge test and clinical risk factors. J Clin Med 7(10):351. https://doi.org/10.3390/jcm7100351

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Agarwal MM (2016) Gestational diabetes mellitus: Screening with fasting plasma glucose. World J Diabetes 7(14):279–289. https://doi.org/10.4239/wjd.v7.i14.279

    Article  PubMed  PubMed Central  Google Scholar 

  13. Benhalima K, Mathieu C, Van Assche A et al (2016) Survey by the European Board and College of Obstetrics and Gynaecology on screening for gestational diabetes in Europe. Eur J Obstet Gynecol Reprod Biol 201:197–202. https://doi.org/10.1016/j.ejogrb.2016.04.003

    Article  PubMed  Google Scholar 

  14. Li M, Lan JR, Liang JL, Xiong XL (2020) Diagnostic accuracy of fasting plasma glucose as a screening test for gestational diabetes mellitus: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 24(21):11172–11186. https://doi.org/10.26355/eurrev_202011_23605

    Article  CAS  PubMed  Google Scholar 

  15. Benhalima K, Van Crombrugge P, Verhaeghe J et al (2014) The Belgian diabetes in pregnancy study (BEDIP-N), a multi-centric prospective cohort study on screening for diabetes in pregnancy and gestational diabetes: methodology and design. BMC Pregnancy Childbirth 14:226. https://doi.org/10.1186/1471-2393-14-226

    Article  PubMed  PubMed Central  Google Scholar 

  16. Benhalima K, Van Crombrugge P, Moyson C et al (2018) The sensitivity and specificity of the glucose challenge test in a universal two-step screening strategy for gestational diabetes mellitus using the 2013 world health organization criteria. Diabetes Care 41(7):e111–e112. https://doi.org/10.2337/dc18-0556

    Article  CAS  PubMed  Google Scholar 

  17. Benhalima K, Van Crombrugge P, Moyson C et al (2019) Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance. Diabetologia 62(11):2118–2128. https://doi.org/10.1007/s00125-019-4961-7

    Article  CAS  PubMed  Google Scholar 

  18. American Diabetes Association (2013) Standards of medical care in diabetes-2013. Diabetes Care 36(Suppl 1):S11-66. https://doi.org/10.2337/dc13-S011

    Article  CAS  Google Scholar 

  19. Durán A, Martín P, Runkle I et al (2010) Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes 2(3):203–211. https://doi.org/10.1111/j.1753-0407.2010.00081.x

    Article  PubMed  Google Scholar 

  20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419. https://doi.org/10.1007/BF00280883

    Article  CAS  PubMed  Google Scholar 

  21. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470. https://doi.org/10.2337/diacare.22.9.1462

    Article  CAS  PubMed  Google Scholar 

  22. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 46(1):3–19. https://doi.org/10.1007/s00125-002-1009-0

    Article  CAS  PubMed  Google Scholar 

  23. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM (2001) Clinically useful estimates of insulin sensitivity during pregnancy: validation studies in women with normal glucose tolerance and gestational diabetes mellitus. Diabetes Care 24(9):1602–1607. https://doi.org/10.2337/diacare.24.9.1602

    Article  CAS  PubMed  Google Scholar 

  24. Retnakaran R, Qi Y, Goran MI, Hamilton JK (2009) Evaluation of proposed oral disposition index measures in relation to the actual disposition index. Diabet Med 26(12):1198–1203. https://doi.org/10.1111/j.1464-5491.2009.02841.x

    Article  CAS  PubMed  Google Scholar 

  25. Devlieger H, Martens G, Bekaert A, Eeckels R (2000) Standaarden van geboortegewicht-voor-zwangerschapsduur voor de vlaamse boreling. Tijdschrift voor geneeskunde 56(1):1–14

    Article  Google Scholar 

  26. IOM (Institute of Medicine) and NRC (National Research Council) (2009) Weight Gain During Pregnancy: Reexamining the Guidelines. Washington, DC.

  27. Saeedi M, Hanson U, Simmons D, Fadl H (2018) Characteristics of different risk factors and fasting plasma glucose for identifying GDM when using IADPSG criteria: a cross-sectional study. BMC Pregnancy Childbirth 18(1):225. https://doi.org/10.1186/s12884-018-1875-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. d’Emden M, McLeod D, Ungerer J, Appleton C, Kanowski D (2020) Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment. PLoS ONE 15(12):e0243192. https://doi.org/10.1371/journal.pone.0243192

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Perucchini D, Fischer U, Spinas GA, Huch R, Huch A, Lehmann R (1999) Using fasting plasma glucose concentrations to screen for gestational diabetes mellitus: prospective population based study. BMJ 319(7213):812–815. https://doi.org/10.1136/bmj.319.7213.812

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Agarwal MM, Dhatt GS, Shah SM (2010) Gestational diabetes mellitus: simplifying the international association of diabetes and pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 33(9):2018–2020. https://doi.org/10.2337/dc10-0572

    Article  PubMed  PubMed Central  Google Scholar 

  31. Agarwal MM, Hughes PF, Punnose J, Ezimokhai M (2000) Fasting plasma glucose as a screening test for gestational diabetes in a multi-ethnic, high-risk population. Diabet Med 17(10):720–726. https://doi.org/10.1046/j.1464-5491.2000.00371.x

    Article  CAS  PubMed  Google Scholar 

  32. Agarwal MM, Dhatt GS, Punnose J (2006) Gestational diabetes: utility of fasting plasma glucose as a screening test depends on the diagnostic criteria. Diabet Med 23(12):1319–1326. https://doi.org/10.1111/j.1464-5491.2006.01987.x

    Article  CAS  PubMed  Google Scholar 

  33. Agarwal MM, Dhatt GS, Punnose J, Koster G (2005) Gestational diabetes in a high-risk population: using the fasting plasma glucose to simplify the diagnostic algorithm. Eur J Obstet Gynecol Reprod Biol 120(1):39–44. https://doi.org/10.1016/j.ejogrb.2004.07.034

    Article  CAS  PubMed  Google Scholar 

  34. Pintaudi B, Di Vieste G, Corrado F et al (2014) Improvement of selective screening strategy for gestational diabetes through a more accurate definition of high-risk groups. Eur J Endocrinol 170(1):87–93. https://doi.org/10.1530/EJE-13-0759

    Article  CAS  PubMed  Google Scholar 

  35. Balaji V, Balaji M, Anjalakshi C, Cynthia A, Arthi T, Seshiah V (2011) Inadequacy of fasting plasma glucose to diagnose gestational diabetes mellitus in Asian Indian women. Diabetes Res Clin Pract 94(1):e21–e23. https://doi.org/10.1016/j.diabres.2011.07.008

    Article  CAS  PubMed  Google Scholar 

  36. Juutinen J, Hartikainen AL, Bloigu R, Tapanainen JS (2000) A retrospective study on 435 women with gestational diabetes: fasting plasma glucose is not sensitive enough for screening but predicts a need for insulin treatment. Diabetes Care 23(12):1858–1859. https://doi.org/10.2337/diacare.23.12.1858

    Article  CAS  PubMed  Google Scholar 

  37. Maegawa Y, Sugiyama T, Kusaka H, Mitao M, Toyoda N (2003) Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy. Diabetes Res Clin Pract 62(1):47–53. https://doi.org/10.1016/s0168-8227(03)00146-3

    Article  PubMed  Google Scholar 

  38. McIntyre HD, Gibbons KS, Ma RCW et al (2020) Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia. Diabetes Res Clin Pract 167:108353. https://doi.org/10.1016/j.diabres.2020.108353

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. McIntyre HD, Moses RG (2020) The diagnosis and management of gestational diabetes mellitus in the context of the COVID-19 pandemic. Diabetes Care 43(7):1433–1434. https://doi.org/10.2337/dci20-0026

    Article  CAS  PubMed  Google Scholar 

  40. Pintaudi B, Fresa R, Dalfrà M et al (2018) The risk stratification of adverse neonatal outcomes in women with gestational diabetes (STRONG) study. Acta Diabetologia 55(12):1261–1273. https://doi.org/10.1007/s00592-018-1208-x

    Article  CAS  Google Scholar 

Download references

Acknowledgments

KB (Katrien Benhalima) and RD are the recipient of a ‘Fundamenteel Klinisch Navorserschap FWO Vlaanderen’.

Funding

This investigator-initiated study was funded by the Belgian National Lottery, the Fund of the Academic studies of UZ Leuven, and the Fund Yvonne and Jacques François-de Meurs of the King Baudouin Foundation. KB (Katrien Benhalima) and RD are the recipient of a ‘Fundamenteel Klinisch Navorserschap FWO Vlaanderen’.

Author information

Authors and Affiliations

Authors

Contributions

KB (Katrien Benhalima), PVC, and CM (Chantal Mathieu) conceived the project. CM (Carolien Moyson), KDW, and AE prepared the data and AL did the statistical analysis. KB (Kaat Beunen) did the literature review. KB (Kaat Beunen) and KB (Katrien Benhalima) wrote the first draft of the manuscript. All authors contributed to the study design, including data collection, data interpretation, and manuscript revision.

Corresponding author

Correspondence to Kaat Beunen.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study protocol was approved by the Institutional Review Boards of all participating centers. All investigations have been carried out in accordance with the principles of the Declaration of Helsinki as revised in 2008.

Consent to participate

All participants provided informed consent prior to inclusion in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article belongs to the topical collection Pregnancy and Diabetes, managed by Antonio Secchi and Marina Scavini.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beunen, K., Neys, A., Van Crombrugge, P. et al. Fasting plasma glucose level to guide the need for an OGTT to screen for gestational diabetes mellitus. Acta Diabetol 59, 381–394 (2022). https://doi.org/10.1007/s00592-021-01812-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-021-01812-9

Keywords

Navigation